Biotechnology News

March 19, 2014

REHOVOT, Israel--(BUSINESS WIRE)--Evogene Ltd. (NYSE:EVGN)(TASE:EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, announced today its financial results for the fourth...

March 19, 2014

BARCELONA, Spain--(BUSINESS WIRE)--100 million Euro fund to include up to 15 companies in the pharmaceutical and medical device and diagnostics segments.

March 19, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--CTP-499 48 week Phase 2 clinical results in patients with diabetic kidney disease will be presented at the National Kidney Foundation 2014 Spring Clinical Meeting.

March 19, 2014

SAN DIEGO--(BUSINESS WIRE)--Daylight Solutions, Inc., a leading manufacturer of molecular detection and imaging solutions in the mid-infrared, today announced the launch of the world’s first commercially available laser-based infrared microscopy...

March 19, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today that Dr. Patrizia Fanara, Vice President of Neuroscience at KineMed, will give the presentation...

March 19, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Mystic Pharmaceuticals appoints Gerald D. Cagle Ph.D. and Grady Rylander M.D. to Ophthalmic Scientific Advisory Board.

March 19, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative Company dedicated to the development of orphan oncology products, announced major advancements in the licensing strategy of Sitavig® (acyclovir Lauriad®)...

March 19, 2014

TOKYO--(BUSINESS WIRE)--Shiseido Co., Ltd. (TOKYO:4911) has long focused its research on skin immunity as an important means of maintaining skin’s health, and protecting it from external and internal stressors that can lead to dermatologic...

March 19, 2014

RAYNHAM, Mass.--(BUSINESS WIRE)--Medrobotics Corp., a medical robotics company, announced today they received the CE mark for the Flex® System and will initiate a limited commercial launch of the product in select European markets.

March 18, 2014

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of...

March 18, 2014

BOSTON--(BUSINESS WIRE)--Halloran Consulting Group, Inc. (Halloran) today announced the recent hiring of Sonna Patel-Raman, Ph.D., formerly with the Food and Drug Administration where she served as Branch Chief. Halloran is a management...

March 18, 2014

ZURICH & NEW YORK--(BUSINESS WIRE)--EffRx Pharmaceuticals has established a worldwide collaboration with Kadmon Corporation to generate effervescent formulations of certain Kadmon products.

March 18, 2014

MIAMI--(BUSINESS WIRE)--BioFlorida to host LatAm Life Sciences Conference. The conference will take place Thursday-Friday, March 27-28 at the Sofitel Miami Hotel and Florida International University.

March 18, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext: MKEA, FR0010609263), leader in the optical biopsy market, announced today that three prominent French private clinics are now equipped with Cellvizio and providing...

March 18, 2014

HOUSTON--(BUSINESS WIRE)--CompanionDx™ Reference Lab (www.companiondxlab.com), a high-complexity CLIA-certified laboratory specializing in pharmacogenomics, cancer...

March 18, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Within the framework of a new collaboration agreement, Trendlines Labs will take part in developing new devices to meet clinical needs identified by doctors at Sheba Medical Center. Trendlines Labs, the in-house...

March 18, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced the launch of its fourth integrated annual review (www.pfizer.com/annual), which summarizes the company’s...

March 18, 2014

REHOVOT, Israel--(BUSINESS WIRE)--Pharma Two B is enrolling patients for a Phase IIb study of its combination product, P2B001, for the treatment of the early stages of Parkinson’s disease (PD).

March 18, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) announced today that it has priced an underwritten public offering of $52 million.

March 18, 2014

GOTHENBURG, Sweden--(BUSINESS WIRE)--Ascom signs large service agreement
With an order for a total value of 14.1 million NOK (1.7 million €), Ascom has signed one of its largest service contracts in the Nordic region. The agreement is

March 18, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND will report year-end December 31, 2013 financial results on Tuesday, March 25, 2014. Management will host a webcast conference call at 8:30 a.m., ET.

March 18, 2014

BURLINGAME, Calif.--(BUSINESS WIRE)--Igenica Biotherapeutics, a company focused on the discovery and development of innovative antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer, announced today that the first patient has...

March 18, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that the underwriters of its previously...

March 18, 2014

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Sparton Corporation (NYSE:SPA) announces that it completed an all-cash transaction to acquire Aubrey Group, Inc., an $8 million revenue business, on March 17, 2014. Aubrey will continue to service its current...

March 18, 2014

SAN ANTONIO--(BUSINESS WIRE)--GenSpera treats first patients in G-202 glioblastoma Phase II trial.

March 18, 2014

SAN ANTONIO--(BUSINESS WIRE)--CeloNova BioSciences announced FDA approval to start an investigative device exemption (IDE) trial for its novel coronary stent system – the Cobra PzF™ coronary stent system.

March 18, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) has initiated a Phase IIa clinical study of IW-3718 in patients suffering from GERD who have not responded adequately to treatment with a PPI.

March 18, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Three top executives from Theorem Clinical Research will be on the agenda at the 23rd Annual Partnerships in Clinical Trials in Las Vegas, March 31-April 2.

March 18, 2014

PHOENIX--(BUSINESS WIRE)--After three rounds of live pitching at Talking Stick Resort on March 6th and 7th, Pinnacle Transplant Technologies emerged victorious and was crowned the 2014 Venture Madness Champion. In addition to the prestigious...

March 18, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus has signed a distributor agreement for its consulting services with China's Research Institute for Liver Diseases (RILD), a prominent contract research organization based in Shanghai.

March 18, 2014

NEW YORK--(BUSINESS WIRE)--A new high-performance centrifuge system, featuring a high-capacity carbon fiber rotor, accelerates bioprocessing with higher volumes to reduce cycle times. Designed to improve productivity and ensure sample safety and...

March 18, 2014

NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)--The International Myeloma Foundation and the EuroFlow consortium are introducing a new automated, highly sensitive flow cytometry method for detecting minimal residual disease (MRD) in myeloma.

March 18, 2014

NEW YORK--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced new innovations in cell culture and bioprocessing technologies to address the evolving requirements of biologic drug discovery and...

March 18, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro announces receipt of complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for their riboflavin ophthalmic solution/KXL® System.

March 18, 2014

NEW YORK--(BUSINESS WIRE)--A new family of single-use bioreactor controller platforms from technology collaborator Applikon Biotechnology provide the versatility and performance required for both highly configurable cGMP and cost-effective...

March 18, 2014

NEW YORK--(BUSINESS WIRE)--New bioreactor controllers for use with Thermo Scientific single-use systems, developed with technology integration collaborator Finesse, offer biopharmaceutical companies the choice, performance and flexibility...

March 18, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) announced that the U.S. Food and Drug Administration (FDA) has extended the initial Prescription Drug User Fee Act (PDUFA) date for its review of the Biologics License Application (BLA...

March 18, 2014

WASHINGTON--(BUSINESS WIRE)--Karen A. Noonan has joined ACRO in the newly created position of Vice President, Global Regulatory Policy. John Lewis to serve as Senior Vice President, Policy and Public Affairs.

March 18, 2014

PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva Systems files registration statement for proposed follow-on offering.

March 18, 2014

ZHANGJIAJIE, China--(BUSINESS WIRE)--Jinchi Biotech Ltd., a biotechnology company based in Zhangjiajie, Hunan Province, today announced that they intend to list on the National Stock Exchange of Australia, followed by a subsequent secondary...

March 18, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) today announced positive results from its phase IIa clinical trial assessing Dysport® in the treatment of Neurogenic Detrusor Overactivity (NDO) in patients...

March 18, 2014

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene SA (Paris:TNG) announced today the closing of the acquisition of Jennerex, Inc. by SillaJen. Philippe Archinard, Chairman and Chief Executive Officer of Transgene, said: “We are very...

March 17, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc. announced today the release of MalaCards, Version 1.05. The new release is available at www.malacards.org. MalaCards is a...

March 17, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), today reported financial results for the fourth quarter and year ended December 31, 2013 and highlighted its fourth quarter and recent corporate accomplishments. Fourth Quarter and...

March 17, 2014

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Reports Fourth Quarter 2013 Financial Results

March 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a life sciences company focused on the development and commercialization of novel drug delivery technologies as well as biopolymer devices for the treatment of spinal...

March 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron (Nasdaq:XLRN) and Celgene will present interim data from an ongoing phase 2a study of sotatercept in patients with end stage renal disease at the National Kidney Foundation 2014 Meeting.